Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.

Revenue projections:

Revenue projections for LALPATHLAB
Revenue projections for LALPATHLAB

Dr. Lal PathLabs Limited's revenue is projected to decrease from last year, a development that could lead investors to adopt a more cautious approach. A revenue decline can negatively affect profitability, signaling challenges for the company and making it less attractive for those seeking solid financial performance.

Financial Ratios:

currentRatio 3.388000
forwardPE 40.822197
debtToEquity 7.133000
earningsGrowth 0.831000
revenueGrowth 0.105000
grossMargins 0.608390
operatingMargins 0.220050
trailingEps 58.450000
forwardEps 29.380000

LALPATHLAB's current ratio, being 3.388, means the company is well-positioned to meet its short-term debt obligations. This reflects LALPATHLAB's strong liquidity, as its cash reserves and current assets provide more than enough coverage for its immediate liabilities.
Positive earnings and revenue growth for Dr. Lal PathLabs Limited suggest that the company is expected to grow its business. This trend reflects strong financial performance, with continued profitability and sales increases indicating a bright outlook for future expansion.
Positive gross and operating margins for LALPATHLAB demonstrate the company's profitability. These margins reflect strong financial performance, with efficient operations contributing to the company's ability to generate consistent profits.
LALPATHLAB's forward EPS being lower than its trailing EPS indicates that the company's earnings are projected to decrease. This suggests that LALPATHLAB may struggle to maintain profitability at previous levels, potentially affecting its financial outlook.

Price projections:

Price projections for LALPATHLAB
Price projections for LALPATHLAB

Price projections for Dr. Lal PathLabs Limited have been gradually reduced, reflecting growing uncertainty about the company's future performance. The downward revisions indicate analysts are lowering their expectations for Dr. Lal PathLabs Limited's market trajectory.

Insider Transactions:

Insider Transactions for LALPATHLAB
Insider Transactions for LALPATHLAB


LALPATHLAB experienced 46 selling transactions, with market price of 3095.047814410666.No sell transactions took place in the period under consideration.Investors are purchasing LALPATHLAB more frequently than selling it near the current price levels, which might point to a bullish sentiment. This pattern could be interpreted as a favorable outlook for the stock's future.

Recommendation changes over time:

Recommendations trend for LALPATHLAB
Recommendations trend for LALPATHLAB


Dr. Lal PathLabs Limited has been receiving a buy bias from analysts, signaling strong confidence in the stock's future performance. This positive outlook might drive investors to view Dr. Lal PathLabs Limited as an attractive option for their portfolios, positioning the company as a stable and profitable investment choice.